NEW BIOSIMILAR RECORD
Through a joint effort, we have succeeded in switching 90% of adalimumab use to a new biosimilar drug. In just three weeks.
Expectations were high when a new agreement on an adalimumab biosimilar entered into force just before Christmas. Partly because the new biosimilar would replace the world's top-selling drug; Humira. But also because Denmark has proven to be one of the best countries in the world for rapid introduction of new biosimilar drugs at hospitals.
In fact, expectations were so high that, according to Amgros, the regions could anticipate annual savings of DKK 335 million.
Reality now confirms that these savings will materialise. And even more than that. The most recent figures from Amgros show that hospitals have in fact succeeded in switching 90% of their use of Humira to new biosimilar drugs. After just three weeks.
This is an impressive result. Normally, a biosimilar drug does not achieve a market share of this size until after two to three months. In fact, we have never before seen a biosimilar switch happen so fast. Neither in Denmark, nor in any other country.
The activities and tasks we perform at Amgros are very diverse, and they involve cooperation with a large number of external stakeholders. Our organisation defines what we do and who our cooperation partners should contactREAD MORE
What is the core task at Amgros, and how do we do this? The answers are in this presentation film, which also puts a face some of our most important cooperation partners.READ MORE
In a complex landscape with many players, our focus is on securing solid operations, while at the same time thinking innovatively and being flexible and agile.READ MORE
Amgros is owned by the five regions and headed by a political board and an executive management.READ MORE
I’m responsible for overall communication at Amgros, including PR. And I help to ensure that we communicate with the surrounding world in an open and engaging manner.
My job is to ensure that Amgros creates value for our owners in the regions. And that Amgros is the partner who gets things done.